Voyager Therapeutics VYGR Institutional Ownership

Voyager Therapeutics, Inc. (NASDAQ:VYGR) has 138 institutional investors that have filed 13F reports for the period ending June 2026.

• They owned 58.1% of outstanding stock in June 2026, up from 56.3% the prior quarter.
• Their total shares held in VYGR increased 6.71% from the prior quarter, while the number of investors in Voyager Therapeutics increased 24.32% year over year.
• During the quarter, 80 of these 138 funds increased positions in VYGR, 34 reduced exposure, and 24 held steady.
• Altogether, these fund groups held 35.21Mn shares in VYGR by June 2026, up by 2.21Mn shares quarter on quarter, and up 2.13Mn shares year over year.
• BlackRock, Inc. holds the largest position in VYGR at 5.17Mn shares as of June 30, 2026, or 8.54% of shares outstanding.
• The most significant purchases of VYGR for the quarter ending June 2026 came from MILLENNIUM MANAGEMENT LLC (1.01Mn), CITADEL ADVISORS LLC (419.4K), TWO SIGMA INVESTMENTS, LP (332.86K), GEODE CAPITAL MANAGEMENT, LLC (280.51K), PANAGORA ASSET MANAGEMENT INC (231.08K).
• The largest sales of VYGR for the quarter ending June 2026 came from Erste Asset Management GmbH (456.24K), BlackRock, Inc. (396.32K), Vestal Point Capital, LP (377.94K), Altshuler Shaham Ltd (131.72K), Patriot Financial Group Insurance Agency, LLC (109.68K).
• Business Quant data shows the 10 biggest positions in Voyager Therapeutics as of June 2026 are held by BlackRock, Inc. (5.17Mn), MILLENNIUM MANAGEMENT LLC (4.44Mn), ARMISTICE CAPITAL, LLC (3.44Mn), Vestal Point Capital, LP (2.62Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.35Mn), GEODE CAPITAL MANAGEMENT, LLC (1.33Mn), Opaleye Management Inc. (1.18Mn), State Street Corp (1.08Mn), TWO SIGMA INVESTMENTS, LP (948.52K), DIMENSIONAL FUND ADVISORS LP (838.18K).